Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 25;389(10071):847-860.
doi: 10.1016/S0140-6736(16)31392-7. Epub 2016 Nov 1.

The global burden of women's cancers: a grand challenge in global health

Ophira Ginsburg  1 , Freddie Bray  2 , Michel P Coleman  3 , Verna Vanderpuye  4 , Alexandru Eniu  5 , S Rani Kotha  6 , Malabika Sarker  7 , Tran Thanh Huong  8 , Claudia Allemani  3 , Allison Dvaladze  9 , Julie Gralow  9 , Karen Yeates  10 , Carolyn Taylor  11 , Nandini Oomman  12 , Suneeta Krishnan  13 , Richard Sullivan  14 , Dominista Kombe  15 , Magaly M Blas  16 , Groesbeck Parham  17 , Natasha Kassami  18 , Lesong Conteh  18
Affiliations
Review

The global burden of women's cancers: a grand challenge in global health

Ophira Ginsburg et al. Lancet. .

Abstract

Every year, more than 2 million women worldwide are diagnosed with breast or cervical cancer, yet where a woman lives, her socioeconomic status, and agency largely determines whether she will develop one of these cancers and will ultimately survive. In regions with scarce resources, fragile or fragmented health systems, cancer contributes to the cycle of poverty. Proven and cost-effective interventions are available for both these common cancers, yet for so many women access to these is beyond reach. These inequities highlight the urgent need in low-income and middle-income countries for sustainable investments in the entire continuum of cancer control, from prevention to palliative care, and in the development of high-quality population-based cancer registries. In this first paper of the Series on health, equity, and women's cancers, we describe the burden of breast and cervical cancer, with an emphasis on global and regional trends in incidence, mortality, and survival, and the consequences, especially in socioeconomically disadvantaged women in different settings.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig 1a
Fig 1a
Global map of the age-standardised (world) incidence rates of female breast cancer in 2012, with the range divided into quintiles. Source: GLOBOCAN (http://globocan.iarc.fr)
Fig 1b
Fig 1b
Global map of the age-standardised (world) mortality rates of female breast cancer in 2012, with the range divided into quintiles. Source: GLOBOCAN (http://globocan.iarc.fr)
Fig 1c
Fig 1c
Global map of the age-standardised (world) incidence rates of cervical cancer in 2012, with the range divided into quintiles. Source: GLOBOCAN (http://globocan.iarc.fr)
Fig 1d
Fig 1d
Global map of the age-standardised (world) mortality rates of cervical cancer in 2012, with the range divided into quintiles. Source: GLOBOCAN (http://globocan.iarc.fr)
Figure 2
Figure 2
Global distribution of age-standardised 5-year net survival (%) for women diagnosed aged 15-99 years with (a) breast or (b) cervical cancer during 2005–09, by continent and country. Legend: Survival estimates for each country are ranked from highest to lowest within each continent: Africa (grey), America (Central and South) (red); America (North) (light red); Asia (yellow); Europe (blue); Oceania (green). Error bars represent 95% confidence intervals. Survival estimates are flagged as follows: *=100% coverage of national population; †=not age-standardised, or §=less reliable because the only estimate(s) available are from a registry or registries in this category.
Figure 3
Figure 3
The proportion of new cases of cervical and breast cancer in 2012 compared with the total cancer burden from all cancers combined in both sexes by country and four-level Human Development Index (HDI), and sort by HDI within these quartiles. Source: GLOBOCAN (http://globocan.iarc.fr)
Figure 4
Figure 4
Estimated annual percentage change (EAPC) 1993-2007 based on cancer incidence obtained from cancer registries included in several volumes of Cancer Incidence in Five Continents (top). Predicted number of breast and cervical cases (thousands) in 2030 assuming average trends in the EAPC are observed in every country up to 2030 seen in the incidence series, or assuming rates remain unchanged in every country from those estimated in GLOBOCAN in 2012.
Figure 5
Figure 5
Age-adjusted DALYs per 100 000 population for cervical and breast cancer in 2008 and four-level Human Development Index. DALYs=disability-adjusted life-years. YLL=years of life lost. YLD=years of life lived with disability. Source: Soerjomataram et al.
See this image and copyright information in PMC

Comment in

References

    1. Vos T, Barber RM, Bell B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990– 2013: a systematic analysis for the Global Burden of Disease Study 2013. [accessed online August 8, 2015];Lancet. 2015 doi: 10.1016/S0140-6736(15)60692-4. ePub June 7. - DOI - PMC - PubMed
    1. Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840–50. - PubMed
    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359–E386. - PubMed
    1. Bosch FX, Robles C, Díaz M, et al. HPV-FASTER: Broadening the scope for prevention of HPV-related cancer. Nat Rev Clin Oncol. 2015 Sep 1; doi: 10.1038/nrclinonc.2015.14. - DOI - PubMed
    1. Sullivan R, Olusegun IA, Anderson BO, et al. Cancer surgery: delivering safe, affordable and timely cancer surgery. The Lancet Oncology. 2015;16:1193–1224. - PubMed

Publication types